Skip to main content
Top

ESR Journals editors’ joint statement on Guidelines for the Use of Large Language Models by Authors, Reviewers, and Editors

Published in:

Excerpt

The impact of artificial intelligence (AI)-assisted technologies, such as Large Language Models (LLMs), chatbots, or image creators, on biomedical publishing was discussed by the editors of radiology journals at the annual Radiology Editors’ Forum, held on August 11–12, 2023, in Chicago, Illinois. The forum was attended by over 40 individuals, representing 30 biomedical imaging journals from 9 countries. In addition to considering the May 2023 ICMJE update [1], the editors considered relevant statements regarding contributions by AI-assisted technologies from other publication committees, associations, and societies, including the World Association of Medical Editors (WAME), the Committee on Publication Ethics (COPE), and the Council of Science Editors (CSE) policies [24]. New NIH guidelines to address the role of generative AI-assisted review of submitted applications were also reviewed [5], as well as policies developed by various medical journals and medical publishers [612]. At the conclusion of the forum, the following policies were endorsed in principle. With this article, the Editors-in-Chief of the ESR Journals adapt these policies to their journals. It is obvious that generative AI tools will continue to quickly evolve and develop new possibilities in our daily lives. The statements and policies will need to be re-evaluated and updated regularly. …
Title
ESR Journals editors’ joint statement on Guidelines for the Use of Large Language Models by Authors, Reviewers, and Editors
Authors
Bernd Hamm
Luis Marti-Bonmati
Francesco Sardanelli
Publication date
01-12-2024
Publisher
Springer Vienna
Published in
Insights into Imaging / Issue 1/2024
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-023-01600-9
This content is only visible if you are logged in and have the appropriate permissions.

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

1.75 AMA PRA Category 1 Credits

Explore using biomarker testing to interpret results and guide treatment strategies through an interactive patient simulation and unique educational escape rooms.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more
Image Credits
Alzheimer’s disease in the biomarker era: preparing the multidisciplinary care team/© Springer Healthcare IME, Navigating neuroimaging in Alzheimer’s care: Practical applications and strategies for integration/© Springer Health+ IME